Oncology & Cancer

Breast cancer patients could benefit from controversial hormone

An international team of researchers involving the University of Adelaide is tackling the controversy over what some scientists consider to be a "harmful" hormone, arguing that it could be a game changer in the fight against ...

Oncology & Cancer

The importance of keeping silent... in breast cancer cells

Sometimes, the silencing of a gene is as important as its activation. Nonetheless, up to now, most studies on hormone-mediated gene regulation have focused on researching the factors that influence the activation of certain ...

Oncology & Cancer

Cross talk between hormone receptors has unexpected effects

One of the first clues pathologists look for in tissue from a newly diagnosed breast cancer patient is the estrogen receptor, a nuclear protein that converts hormonal messages in the bloodstream into instructions for the ...

Obstetrics & gynaecology

Case report: Hidradenoma papilliferum in pregnancy

(HealthDay)—Hidradenoma papilliferum in association with pregnancy has been illustrated in a case report published online Aug. 12 in the Journal of Cutaneous Pathology.

Oncology & Cancer

ASCO guidelines: biomarker use in metastatic breast CA treatment

(HealthDay)—Biomarkers can be used to guide decisions on systemic therapy for women with metastatic breast cancer, according to the American Society of Clinical Oncology Clinical Practice Guideline published online July ...

Oncology & Cancer

Treating breast cancer with progesterone could aid survival

A special technique where breast cancer cells are "rescued" for research has been developed at the University of Adelaide. Coupled with advanced scientific technologies pioneered by Cambridge University this has provided ...

page 4 from 8